Orchestra BioMed Holdings, Inc.
OBIO
$4.49
-$0.08-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 138.66% | -35.02% | -21.17% | -39.31% | -26.03% |
| Total Depreciation and Amortization | -2.38% | 6.58% | 9.46% | 12.16% | 16.67% |
| Total Amortization of Deferred Charges | 106.45% | -- | -- | -- | 933.33% |
| Total Other Non-Cash Items | -6.34% | 57.14% | 27.46% | 42.25% | 105.04% |
| Change in Net Operating Assets | -801.03% | 497.65% | -88.34% | 46.02% | -1,075.00% |
| Cash from Operations | 83.23% | -6.20% | -52.14% | -26.70% | -23.36% |
| Capital Expenditure | 68.87% | -355.88% | 68.22% | -1,300.00% | -3,633.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -480.59% | -6,223.84% | 55.64% | 123.39% | -109.19% |
| Cash from Investing | -371.94% | -7,027.11% | 56.91% | 121.79% | -111.32% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,925.49% | 284.30% | -100.00% | 405.56% | -66.67% |
| Repurchase of Common Stock | 14.91% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.45% | -- | -- | -- | -- |
| Cash from Financing | -9.23% | 408.13% | -350.29% | -1,744.44% | 230.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.96% | 1,129.55% | 3.08% | 45.92% | -129.13% |